CCO Interactive Case Challenges
Treatment of Nonsmall-Cell Lung Cancer
Interactive Case Challenges
Treatment of Stage III Nonsmall-Cell Lung Cancer
Program Director:
Corey J. Langer, MD
- Howard (Jack) L. West, MD
|
|
|
 Choose the therapeutic modalities that will provide this patient with optimal outcomes, while minimizing treatment-related adverse events Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the results of recent clinical studies regarding new chemotherapy and targeted therapy approaches for NSCLC
- Describe the incidence and management of short- and long-term safety issues associated with various treatment regimens
|
A 74-Year-Old Woman With Stage IV Nonsmall-Cell Lung Cancer
Program Director:
Corey J. Langer, MD
|
|
What impact should this patient’s age have on treatment decisions? Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the results of recent clinical studies regarding new chemotherapy and targeted therapy approaches for nonsmall-cell lung cancer
- Describe the incidence and management of short- and long-term safety issues associated with various treatment regimens
- Review data on current efforts to identify patients who are most likely to derive benefit from specific therapeutic approaches based on age, history, preexisting comorbid medical conditions, and other prognostic factors
|
A 52-Year-Old Woman With Stage IV Nonsmall-Cell Lung Cancer
Program Director:
Corey J. Langer, MD
|
|
What options are available to patients with advanced, nonresectable NSCLC? Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the use of systemic therapy in patients with advanced, unresectable nonsmall cell lung cancer
- Describe the incidence and management of short- and long-term safety issues associated with various treatment regimens
- Review data on targeted therapy for advanced nonsmall cell lung cancer
|
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|